Neuronetics STIM Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 48%-0.5pp | 48.5%-2.0pp | 50.4%-5.7pp | 56.2%-7.4pp | 63.5%-8.8pp | |
| Operating margin | -19.4%+1.7pp | -21.1%+8.1pp | -29.2%+5.3pp | -34.4%+8.8pp | -43.3%+2.9pp | |
| Net margin | -24.5%+1.7pp | -26.1%+8.1pp | -34.3%+9.7pp | -43.9%+10.3pp | -54.2%+4.1pp | |
| Returns | ||||||
| Return on equity | -152.4%+3.4pp | -155.7%+86.5pp | -242.3%-32.5pp | -209.7%-56.0pp | -153.7%-12.5pp | |
| Return on invested capital | -32.1%+3.5pp | -35.6%+23.8pp | -59.5%-3.3pp | -56.2%-0.9pp | -55.3%-1.6pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.1× | 1.1×-0.1× | 1.2×+0.2× | 1×+0.2× | 0.7×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.3× | 2×-0.2× | 2.2×+0.2× | 2×-0.4× | 2.4×+0.6× | |
| Leverage | ||||||
| Debt-to-equity | 6.4×+2.4× | 4×+0.7× | 3.3×+0.3× | 3×+0.6× | 2.3×-0.7× | |
| Per Share | ||||||
| Book value per share | $0.19-43.8% | $0.34-16.5% | $0.41-0.9% | $0.41-28.9% | $0.58-33.9% | |
| Valuation | ||||||
| Market capitalization | $90.46M-59.6% | $94.51M-47.6% | $180.52M-22.5% | $233M-2.4% | $238.76M+166% | |
| Price / sales | 0.6×-1.4× | 0.6×-0.8× | 1.4×-0.7× | 2.1×-0.6× | 2.7×+1.5× | |
| Price / book | 6.8×-1.4× | 4.2×-2.4× | 6.6×-2.0× | 8.6×+1.8× | 6.7×+3.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Neuronetics's profit margins?
- Neuronetics (STIM) runs a 48.0% gross margin and a -19.4% operating margin, with a -24.5% net margin.
- Where do Neuronetics's ratios come from?
- Every ratio is computed from Neuronetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
